AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients ...Middle East

TAIPEI, May 21, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive results from its Phase 1/2a randomized, double-blind,...

Read More Details
Finally We wish PressBee provided you with enough information of ( AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients )

Also on site :

• Trader Joe's is Giving This Viral Chocolate Bar Its Own Spin and Shoppers 'Can't Wait' To Try It
• Sputnik V creator warns of global ‘cat flu’ pandemic
• Former Microsoft engineer fired over protest on Israel AI ties